PSENEN
PSENEN (presenilin enhancer, gamma-secretase subunit, also known as PEN2 or PEN-2) is an essential subunit of the gamma-secretase complex, an intramembrane endoprotease that processes Notch receptors and amyloid-beta precursor protein. It also acts as a regulator of AMPK activity. Browse Assay Genie's current range of PSENEN research reagents below, or read on for the biology behind the target.
PSENEN is an essential subunit of the gamma-secretase complex, an endoprotease complex that catalyses the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein). Through its role in processing key regulatory proteins, and by regulating cytosolic CTNNB1 levels, the complex contributes to Notch and Wnt signalling cascades and the downstream processes they control. PSENEN modulates both the endoproteolysis of presenilin and gamma-secretase activity, and the encoded protein is required for the activity and accumulation of gamma-secretase.
Beyond the complex, PSENEN regulates AMP-activated protein kinase (AMPK) activity in response to calorie restriction. It binds metformin, an antidiabetic drug, which promotes its association with ATP6AP1, a subunit of the V-ATPase complex. This leads to V-ATPase inhibition on lysosomes and AMPK activation via the AXIN1-STK11/LKB1 axis. The PSENEN protein belongs to the PEN-2 family and is found in the endoplasmic reticulum membrane, the Golgi stack membrane and the cell membrane. The human PSENEN gene has orthologues named Psenen in mouse and rat, and alternative splicing results in multiple transcript variants.
Presenilins are required for intramembranous processing of some type I transmembrane proteins. Notch signalling mediates a wide range of developmental cell fates, while processing of the beta-amyloid precursor protein generates neurotoxic amyloid beta peptides, the major component of senile plaques associated with Alzheimer's disease. Mutations causing haploinsufficiency for PSENEN cause familial acne inversa-2 (ACNINV2). The gene was previously named presenilin enhancer 2 homolog (C. elegans) and belongs to the HGNC group of gamma-secretase complex subunits.
PSENEN is required for the activity and accumulation of gamma-secretase and modulates presenilin endoproteolysis, making it central to studies of complex assembly.
Gamma-secretase processes beta-amyloid precursor protein to generate amyloid beta peptides, the main component of senile plaques linked to Alzheimer's disease.
The gamma-secretase complex cleaves Notch receptors and influences Wnt signalling, in part by regulating cytosolic CTNNB1 levels.
PSENEN binds metformin and links V-ATPase inhibition on lysosomes to AMPK activation through the AXIN1-STK11/LKB1 axis.
PSENEN is an essential subunit of the gamma-secretase complex, which cleaves membrane proteins such as Notch receptors and APP within the membrane. It modulates presenilin endoproteolysis and gamma-secretase activity, and separately regulates AMPK in response to calorie restriction.
PSENEN is also called PEN2 or PEN-2, and UniProt lists the protein as gamma-secretase subunit PEN-2. Its earlier gene name was presenilin enhancer 2 homolog (C. elegans). NCBI notes that alternative splicing produces multiple transcript variants.
Mutations causing haploinsufficiency of PSENEN cause familial acne inversa-2 (ACNINV2). The gene has mouse and rat orthologues, both named Psenen, so rodent studies are possible; check the datasheet of any product for its validated reactivity.
Other gamma-secretase subunits, Notch and Wnt pathway proteins, and AMPK pathway components related to PSENEN.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NZ42; product specifications from Assay Genie datasheets.